Contemporary Assessment of Long-Term Survival Rates in Patients With Stage I Nonseminoma Germ-Cell Tumor of the Testis: Population-Based Comparison Between Surveillance and Active Treatment After Initial Orchiectomy: Clinical Genitourinary Cancer

E Mazzone, FA Mistretta, S Knipper, Z Tian, C Palumbo, G Gandaglia, D Soulieres, D Tilki, F Montorsi, SF Shariat, F Saad, A Briganti, PI Karakiewicz

Research output: Contribution to journalArticlepeer-review

Abstract

In contemporary stage I nonseminoma germ-cell tumor of the testis (NSGCTT) patients, increasing use of surveillance and chemotherapy, in concordance with guideline recommendations, is evident. Long-term survival rates were comparable between surveillance and active treatment (AT) patients. Among AT, retroperitoneal lymph node dissection was associated with better long-term survival outcomes. These results confirm the contemporary adherence to guideline recommendations and also confirm the safety of surveillance in patients with stage I NSGCTT. © 2019 Elsevier Inc.
Original languageEnglish
Pages (from-to)e1153-e1162
JournalClinical Genitourinary Cancer
Volume17
Issue number6
DOIs
Publication statusPublished - 2019

Fingerprint Dive into the research topics of 'Contemporary Assessment of Long-Term Survival Rates in Patients With Stage I Nonseminoma Germ-Cell Tumor of the Testis: Population-Based Comparison Between Surveillance and Active Treatment After Initial Orchiectomy: Clinical Genitourinary Cancer'. Together they form a unique fingerprint.

Cite this